↓ Skip to main content

Serum sclerostin is an independent predictor of mortality in hemodialysis patients

Overview of attention for article published in BMC Nephrology, December 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
41 Mendeley
Title
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Published in
BMC Nephrology, December 2014
DOI 10.1186/1471-2369-15-190
Pubmed ID
Authors

Flávia Letícia Carvalho Gonçalves, Rosilene M Elias, Luciene M dos Reis, Fabiana G Graciolli, Fernando Godinho Zampieri, Rodrigo B Oliveira, Vanda Jorgetti, Rosa MA Moysés

Abstract

Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk factor for death is not well established. The purpose of this study was to test whether serum Scl would be associated with mortality.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 2%
France 1 2%
Unknown 39 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 20%
Researcher 5 12%
Student > Master 5 12%
Professor 4 10%
Lecturer 3 7%
Other 10 24%
Unknown 6 15%
Readers by discipline Count As %
Medicine and Dentistry 16 39%
Nursing and Health Professions 8 20%
Biochemistry, Genetics and Molecular Biology 1 2%
Veterinary Science and Veterinary Medicine 1 2%
Psychology 1 2%
Other 3 7%
Unknown 11 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 August 2015.
All research outputs
#15,311,799
of 22,772,779 outputs
Outputs from BMC Nephrology
#1,442
of 2,463 outputs
Outputs of similar age
#213,891
of 361,258 outputs
Outputs of similar age from BMC Nephrology
#30
of 44 outputs
Altmetric has tracked 22,772,779 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,463 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,258 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.